SEP 04, 2020 11:57 AM PDT

Fecal Transplant Successfully Treats Alcoholism

WRITTEN BY: Annie Lennon

Researchers from Virginia Commonwealth University have found that fecal transplants can reduce drinking behaviors in people addicted to alcohol. 

Fecal microbial transplant (FMT) is a procedure in which doctors transplant fecal matter from a healthy donor to another person. They do so to introduce healthy bacteria to their gut and relieve various health conditions. Although used for millennia in Chinese medicine, interest in the treatment has surged in recent years following breakthroughs in research surrounding the gut microbiome. 

While animal studies have already indicated the potential for FMT to treat negative behaviors caused by alcohol use, the present trial is the first robust, placebo-controlled study of the treatment for alcoholism in humans. For it, the researchers recruited 20 men, all of whom had been clinically diagnosed with alcohol-use disorder (AUD). All participants were in their mind-60’s and were suffering from alcohol-related cirrhosis of the liver. 

During the study, each man either received a placebo or an active FMT taken from a single donor with high levels of certain bacteria (Lachnospiraceae and Ruminococcaceae) usually present at low levels among patients with AUD. After the FMT was administered, patients underwent a variety of physiological and behavioral tests 15 days and six months following the procedure. 

At the 15-day follow up, the researchers found that nine of the ten patients who received the transplant had reduced appetite, as well as fewer alcohol-related metabolites in their urine. Meanwhile, just three of the ten men in the placebo group had similar results. The researchers also noted that after six months, men treated with FMT continued to display fewer AUD-related behaviors. 

“We conclude in this Phase 1 trial that FMT in men with cirrhosis is safe, associated with a reduction in short-term craving and consumption with beneficial microbial change,” write the researchers in their study. “The FMT-assigned group also demonstrated lower AUD-related events over the follow-up, which need to be confirmed and extended in a larger number of patients with AUD.”

 

Sources: HepatologyNew Atlas

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
SEP 23, 2021
Technology
New Glaucoma Drainage Implant Safe And Effective At Reducing Intraocular Pressure
SEP 23, 2021
New Glaucoma Drainage Implant Safe And Effective At Reducing Intraocular Pressure
Glaucoma, which affects an estimated 57 million people worldwide, is an eye condition caused by too much pressure around ...
SEP 23, 2021
Drug Discovery & Development
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
SEP 23, 2021
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
Last week, the United States Food and Drug Administration (FDA) granted approval for the first oral therapy to ...
OCT 14, 2021
Immunology
'Bio-Betters' Form the Next Wave of Cancer Therapies
OCT 14, 2021
'Bio-Betters' Form the Next Wave of Cancer Therapies
  Antibodies are blood proteins with highly specialized functions: to recognize and eliminate bacteria, viruses, an ...
OCT 29, 2021
Health & Medicine
The Happenstance Discovery of Delta 10 THC
OCT 29, 2021
The Happenstance Discovery of Delta 10 THC
The random discovery of Delta 10 is a good example of how cannabis science has only just begun to explore the complexity ...
NOV 08, 2021
Coronavirus
Pfizer Claims Their New COVID-19 Pill Reduces Hospitalization Risk by 89%
NOV 08, 2021
Pfizer Claims Their New COVID-19 Pill Reduces Hospitalization Risk by 89%
Current treatments for COVID-19 have to be administered intravenously, so a pill that could treat patients would be huge ...
NOV 19, 2021
Health & Medicine
Increase in Cannabis Use Disorder in Prenatal Hospitalizations
NOV 19, 2021
Increase in Cannabis Use Disorder in Prenatal Hospitalizations
A recent study by Columbia University and Weill Cornell Medicine researchers found that cannabis use disorder (CUD) in p ...
Loading Comments...